Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
TPKnpCFqRcGBX0fJ